Skip main navigation

Differential Effects of Short-term Hypoxia and Hypercapnia on N-Methyl-d-Aspartate–Induced Cerebral Vasodilatation in Piglets

Originally published 1996;27:1634–1640


    Background and Purpose Recent studies in piglets show that either asphyxia or global cerebral ischemia, which combines effects of hypoxia and hypercapnia, transiently attenuates N-methyl-d-aspartate (NMDA)–induced pial arteriolar dilation. The purpose of this study was to determine individually the effects of hypoxic hypoxia and normoxic hypercapnia on NMDA-dependent cerebrovascular reactivity. In addition, we examined mechanisms involved in reduced cerebral vascular dilation to NMDA.

    Methods In anesthetized piglets, we examined pial arteriolar diameters using a cranial window and intravital microscopy. Arteriolar responses to topically applied NMDA were determined under control conditions and after arterial hypoxia or arterial hypercapnia. In addition, arteriolar responses to NMDA were examined in animals given indomethacin (10 mg/kg IV) or superoxide dismutase (100 U/mL, topical application) before hypoxia.

    Results Under control conditions, application of NMDA produced a dose-related dilation of pial arterioles (eg, 9±1% to 10−5, 15±2% to 5×10−5, and 28±5% to 10−4 mol/L NMDA above baseline, respectively, in the hypoxic group; n=6, P<.05). After transient exposure to 15 minutes of hypoxic hypoxia, arteriolar responses to NMDA were reduced at 30 minutes and at 60 minutes (10−4 mol/L NMDA dilated by 12±5% and 18±5%, respectively; n=6, P<.05). Five minutes of hypoxic hypoxia also reduced dilatation to NMDA. Indomethacin or superoxide dismutase preserved arteriolar responses to NMDA after 15 minutes of hypoxia. Pial arteriolar responses to NMDA remained unimpaired during and after hypercapnia.

    Conclusions Short-term severe hypoxic hypoxia and reventilation impair the NMDA-induced dilatation of pial arterioles. Respiratory acidosis alone does not modify pial arteriolar reactivity to NMDA. The reduced responsiveness of the cerebral blood vessels to NMDA caused by hypoxia appears to be due to action of oxygen radicals.

    Cerebral ischemia and asphyxia are common insults during the perinatal period.1 We have previously reported that 10 minutes of either asphyxia or global cerebral ischemia transiently reduces arteriolar dilatation to NMDA.23 However, the factors affecting arteriolar dilation under these conditions are unclear but may involve modification of the NMDA receptor-ion channel complex. The activity of the complex can be modified by various conditions and agents456 such as acidosis7 and hypoxia,8 which are prominent features of ischemia and asphyxia. Interestingly, we found no studies published on modulation of NMDA-dependent cerebral vasodilatation by arterial hypoxia or hypercapnia alone.

    Accordingly, the aims of the present experiments were to determine the separate effects of hypoxic hypoxia and normoxic hypercapnia on NMDA-dependent vascular reactivity. We tested the hypothesis that arterial hypoxia and hypercapnia would attenuate arteriolar dilation to NMDA. In addition, based on previous observations,2 we have tested the hypothesis that indomethacin pretreatment preserves NMDA-induced arteriolar dilation. Furthermore, we directly tested the hypothesis that changes in arteriolar dilation to NMDA were due to actions of oxygen radicals.

    Materials and Methods

    Newborn (1 to 7 days old) piglets of either sex with body weight of 0.9 to 1.4 kg were used in this study. All procedures were approved by the institution's animal care and use committee. Anesthesia was induced with sodium thiopental (30 mg/kg) followed by intravenous injection of α-chloralose (75 mg/kg). Supplemental doses of α-chloralose were given as needed to maintain a stable level of anesthesia. Animals were intubated by tracheotomy and artificially ventilated with room air. Body temperature was maintained at 37°C to 38°C by a heating pad. Systemic arterial blood pressure was recorded by means of a cannula introduced to the right femoral artery connected to a pressure transducer. The right femoral vein was cannulated for drug administration. The head was fixed in a stereotaxic frame. The scalp was incised, and connective tissue over the parietal bone was removed. A craniectomy for a 19-mm stainless steel/glass cranial window was made in the left parietal bone 10 mm rostral to the coronal suture. The dura was exposed, cut, and reflected over the skull. A cranial window with three needle ports was placed into the hole, sealed by bone wax, and cemented with cynoacrylate ester and dental acrylic. The closed window was filled with aCSF, which was warmed to 37°C and equilibrated with 6% O2 and 6.5 CO2% in N2. The composition of the aCSF was as follows (mmol/L): KCl 2.9, MgCl2 1.4, CaCl2 1.2, NaCl 132, NaHCO3 24.6, urea 6.7, and glucose 3.7. Diameters of pial arterioles were measured with a microscope (Wild M36) equipped with a video camera (Panasonic) and video microscaler (IV-550, For-A Co). After the surgical procedure, the cranial window was gently infused with aCSF several times until a stable baseline was obtained.

    Experimental Protocol

    There were six experimental groups of animals in this study.

    Group 1: Exposure to 15-Minute Hypoxia

    In the first group of piglets (n=6), we examined responses of cerebral arterioles to three different doses of NMDA (10−5, 5×10−5, and 10−4 mol/L) applied topically before and 30 and 60 minutes after a 15-minute exposure to hypoxia. Hypoxia was produced by inhalation of a gas mixture of 7.5% O2/92.5% N2. Arterial blood gas and pH levels were measured at the 5th and the 14th minutes of the hypoxic period.

    Group 2: Exposure to 5-Minute Hypoxia

    To determine how the duration of the hypoxic exposure influences the NMDA-dependent pial arteriolar responsiveness, in a second group of animals (n=5), we recorded the vascular responses before and 30 minutes after 5 minutes of hypoxia.

    Group 3: Exposure to Hypoxia With Indomethacin Treatment

    Previously, we have shown that indomethacin pretreatment preserves NMDA-induced pial arteriolar dilatation after global cerebral ischemia3 or asphyxia.2 Therefore, in the third group of piglets (n=6), we examined responses to NMDA as in group 1, but animals were treated with indomethacin (10 mg/kg IV) 20 minutes before hypoxia.

    Group 4: Exposure to Hypoxia With SOD Treatment

    We have shown previously that SOD can scavenge superoxide anions after ischemia or asphyxia.910 Therefore, in the fourth group of animals (n=6), we examined responses to NMDA under control conditions as in the first group. After vessel diameters returned to baseline, SOD (100 U/mL) was topically applied three to four times for a 30-minute period and allowed to remain under the window during the 15-minute hypoxic exposure. NMDA responsiveness was tested 30 minutes after the hypoxic period.

    Group 5: Exposure to 30-Minute Hypercapnia

    In the fifth group of animals (n=7), we investigated whether normoxic hypercapnia and subsequent acidosis influence the responsiveness of the cerebral blood vessels to NMDA. Vascular responses were evaluated under control conditions and 30 and 60 minutes after exposure to 10% CO2 in air for 30 minutes. Blood gas values and pH were measured at 5, 15, and 25 minutes of hypercapnia.

    Group 6: Exposure to Hypercapnia With Indomethacin Treatment

    In piglets, we have previously shown that 10 mg/kg IV indomethacin blocks prostanoid production to various stimuli and reduces cerebral vasodilator responses to normoxic hypercapnia.11 Therefore, in indomethacin-pretreated animals it was possible to examine the NMDA-induced pial arteriolar responses during persistent respiratory acidosis when changes in diameter were minimal. In this group of piglets (n=6), indomethacin was given 20 minutes before the hypercapnic period, and NMDA responsiveness was tested during and after hypercapnia.

    Group 7: Vascular Responses to SNP and Forskolin After Hypoxia

    In a separate group of animals (n=4), we examined vascular responses to SNP and forskolin before and after 15 minutes of hypoxia to test whether hypoxia alters responsiveness of pial arterioles to other vasodilator substances.


    The drugs used in this study were N-methyl-d-aspartic acid (Sigma), SOD (Sigma), and indomethacin sodium trihydrate (Merck). Appropriate dilutions of NMDA were made with aCSF just before application.

    Statistical Analysis

    Values are presented as mean±SE. When appropriate, data were analyzed with the paired t test or with repeated measures ANOVA, and Student-Newman-Keuls test was performed. Comparisons between treatment groups were made with ANOVA. A value of P<.05 was considered statistically significant.


    Application of NMDA produced a dose-related dilatation of pial arterioles under control conditions (Figs 1 through 4). Baseline mean arterial blood pressure was approximately 60 mm Hg in each group and did not change during application of NMDA.

    Effects of Hypoxia on NMDA Responses

    Inhalation of 7.5% O2 for 15 minutes resulted in a pial arteriolar dilatation. The vasodilator effect developed in 3 to 4 minutes, with a maximal dilation of 33±4% above baseline. At the end of the hypoxic period arteriolar diameter was 121±11 μm, which was approximately 20% above baseline (Table 1, group 1). Arterial Pco2 did not change, whereas arterial Po2 decreased from 91±5 to 22±1 mm Hg during hypoxia. Change in arterial pH indicates development of a slight metabolic acidosis. Arterial blood pressure was kept at normal levels. After the end of 7.5% oxygen inhalation, arteriolar diameters recovered to baseline levels by 10 minutes. Thirty minutes after the hypoxic period, arteriolar diameter was not statistically different from the original baseline. After 15 minutes of hypoxic hypoxia, arteriolar responses to NMDA were reduced at 30 and 60 minutes as well (Table 1; Figs 1 and 2).

    In animals exposed to 5 minutes of hypoxia, the size of the arteriolar dilatation was similar to the first group (Table 1, group 2). Arteriolar diameter was 108±6 μm before and 139±8 μm at the end of the hypoxic period. Five minutes of hypoxic exposure significantly reduced arteriolar dilatation to NMDA. Thirty minutes after the hypoxic period, 10−4 mol/L NMDA dilated pial arterioles by 19±2%, whereas dilation under control circumstances was 30±3% (P<.05, Fig 1).

    Comparing the effects of the 15-minute and 5-minute hypoxic exposures, we found that 15-minute hypoxia reduced the vascular responses to NMDA more than 5-minute hypoxia (Fig 1).

    In group 3, 20 minutes after administration of indomethacin the diameter of the arterioles was 80±2 μm, 12% less than baseline value (Table 1, group 3). In animals pretreated with indomethacin, hypoxia also resulted in cerebral vasodilatation, and arteriolar diameter was 21±10% above the original baseline at the end of the hypoxic period. In contrast to groups 1 and 2, arteriolar responses to each dose of NMDA 30 or 60 minutes after the hypoxic period were not changed significantly (Table 1, Fig 2).

    Topically applied SOD neither altered baseline diameter (102±4 μm under control conditions and 102±5 μm after SOD treatment) nor altered cerebral arteriolar dilation during hypoxia (Table 1, group 4). Mean arterial blood pressure was not influenced by SOD treatment. Thirty minutes after 15 minutes of hypoxic hypoxia, arteriolar responses to NMDA did not differ from responses before hypoxia (Fig 3).

    Effects of Hypercapnia on NMDA Responses

    During hypercapnia, arterial blood pH decreased from 7.45±0.04 to 7.13±0.03 at the 15th minute of the hypercapnic period. Arterial Pco2 rose from 34±1 to 73±3 mm Hg, but arterial Po2 was unchanged from baseline (Table 2, group 5). Hypercapnia caused dilatation of pial arterioles to a degree close to the response evoked by 10−4 mol/L NMDA (Table 2). The diameter of the arterioles was 125±7 μm, 33% above the baseline at the end of the hypercapnic period. Thirty minutes after the hypercapnic period, arteriolar dilation to NMDA did not differ from the values measured under control conditions (Table 2 and Fig 4).

    In the indomethacin-pretreated group (group 6), the hypercapnic response was significantly attenuated compared with the untreated group. However, the vessel diameter increased slightly, by 10% above baseline (115±9 versus 104±4 μm). Arteriolar dilation to NMDA was not different from baseline responses during the hypercapnic period (Table 2, group 6); 10−4 mol/L NMDA dilated pial arterioles by 31±4% during hypercapnia (Fig 4). Although baseline diameters increased slightly by 30 minutes after the hypercapnic period, arteriolar responses to NMDA (either absolute or percent values) were unchanged (Table 2, Fig 4).

    Dilatation of cerebral arterioles in response to SNP was not affected by 15 minutes of hypoxia. Baseline diameter of cerebral arterioles was 104±2 μm in this group (n=4). The increase in diameter was 15±% and 29±2% before and 16±2% and 30±4% 30 minutes after hypoxia in response to 10−6 and 10−5 mol/L SNP, respectively.

    Forskolin at concentrations of 5×10−8 and 5×10−6 mol/L resulted in vasodilation before hypoxia (9±1% and 29±1%, respectively; n=4). Baseline diameters did not differ before and 60 minutes after hypoxia (104±1 versus 102±1 μm; n=4). Hypoxia had no significant effect on vasodilatation: increases in arteriolar diameter were 8±1% and 31±4% after hypoxia.


    We report four important new findings in this study. First, a brief period (5 or 15 minutes) of hypoxic hypoxia is able to impair NMDA-induced dilation of pial arterioles of newborn pigs for at least 30 to 60 minutes. Second, responsiveness of cerebral arterioles to NMDA remains intact during and after 30 minutes of respiratory acidosis. Third, administration of indomethacin before hypoxia preserves the NMDA reactivity of pial arterioles. And fourth, topical application of SOD preserves cerebral arteriolar dilator responses to NMDA. Thus, oxygen radicals appear to play a role in altered arteriolar responses to NMDA after hypoxia.

    Glutamate and NMDA affect cerebral blood vessels secondarily by initiating neuronal NO synthesis.1213 Previous studies by other laboratories14 and by us23 have shown that cerebrovascular responsiveness to topical NMDA did not change with repeated drug application. In addition, the magnitude of arteriolar dilatation to NMDA in the present study was similar to changes reported previously.23 However, several studies on piglets have shown that cerebrovascular responses to several dilator substances and other dilator stimuli are impaired after asphyxia2 or ischemia.315 On the other hand, vasodilation to isoproterenol16 and SNP3 is intact in piglets after global ischemia. Our present data indicate that 15 minutes of severe hypoxia does not alter responsiveness of pial arterioles to NO. Similarly, direct activation of adenylate cyclase by forskolin results in the same vasodilation before and after hypoxia.

    Detailed description of structure and function of the NMDA receptor is available in many reviews.417 In vitro studies revealed that the receptor activity can be modified by extracellular pH18 and oxygen radicals, as well as by other factors.192021 However, it was previously unclear whether acidosis or oxygen radicals have a major influence on cortical NMDA receptor function in vivo.

    Arterial hypoxia and hypercapnia can influence extracellular pH through different mechanisms.22 In the present experiments, inhalation of 10% CO2 resulted in arterial hypercapnia and acidosis by 5 minutes. Arterial pH and CO2 did not change further during the exposure period. Several studies have shown that extracellular brain pH parallels arterial blood pH during arterial hypercapnia.23 Studies on the extracellular pH of the brain during hypoxia reveal that a brief initial transient alkaline shift is followed by acidosis.22 On inhalation of room air after arterial hypercapnia or hypoxia, arterial blood pH returns quickly to baseline levels.2324

    One difficulty with examining the effects of acidosis on arteriolar dilation to NMDA is the change in baseline arteriolar diameter during hypercapnia. Consequently, we took advantage of the ability of indomethacin to suppress arteriolar dilation during hypercapnia.25 Indomethacin does not alter NMDA-induced arteriolar dilation.26 Despite severe acidosis, NMDA-evoked responses remained intact during and after hypercapnia. It is therefore unlikely that extracellular acidosis alone is responsible for changes in NMDA-evoked responses after ischemia or asphyxia.23 However, we cannot completely rule out a depressive effect of H+ on NMDA-induced dilatation at greater levels of acidosis.

    Our present finding is apparently in contrast to deductions based on studies2728 in which acidosis reduced the NMDA-activated inward Ca2+ current. In those experiments the acidosis appeared to be more severe than in our model.

    In contrast to acidosis, we showed that even a brief period of hypoxic stress and reoxygenation induces a persistent change in NMDA-mediated vascular responses. Reduced oxygen supply affects the metabolism of neuronal and glial tissues and causes a rise in extracellular concentration of various vasodilator metabolites.29 These metabolites include adenosine, lactic acid, prostaglandins, NO, and vasoactive peptides. Accumulation of a variety of vasoactive substances in the cerebrospinal fluid could have immediate or sustained effects on NMDA receptor functions. Changes in the composition of endogenous redox compounds associated with hypoxia/reoxygenation could also interact with the NMDA receptor complex.81920

    Information regarding the functional changes of the NMDA receptor itself after hypoxic insults is sparse. Reduced NMDA receptor numbers and [3H]glutamate binding sites have been described immediately or 24 hours after hypoxic exposure in fetal guinea pig cortex8 and neonatal rat brain.30 Conversely, hypoxia enhances ligand binding affinity of the NMDA receptor.8 Thus, based on ligand binding experiments performed ex vivo, it is impossible to predict effects of hypoxia on NMDA-induced pial arteriolar dilation.

    Indomethacin administration alone does not affect NMDA-initiated cerebral hemodynamics, suggesting that cyclooxygenase products do not mediate responses to NMDA.1126 The finding that preadministration of indomethacin restored NMDA-induced pial arteriolar dilation after hypoxia is consistent with our previous results with asphyxia.2 The mechanism of protective action on NMDA-induced arteriolar responsiveness is unclear. Indomethacin blocks prostaglandin synthase31 and prevents free radical production2032 during conversion of PGG2 to PGH2. Our previous data2 indicate that oxypurinol, an oxygen radical scavenger and xanthine oxidase inhibitor, preserves the NMDA-induced dilation after asphyxia. This adds support to the view that oxygen radicals depress NMDA-induced arteriolar dilation. In addition, the present findings with SOD provide strong evidence that oxygen radicals are able to suppress NMDA-induced arteriolar dilation.

    Reduction in neuronal NOS activity after hypoxia could also account for the decrease in NMDA-evoked pial arteriolar dilation. However, we have not found any substantial reduction in NOS activity or neuronal NOS levels after complete ischemia in a global ischemia model,3 while NMDA-induced arterial dilatation was impaired significantly. Accordingly, Groenendaal et al33 showed that hypoxia did not alter NOS activity measured ex vivo in piglets.

    Although the role of NMDA receptors in hypoxia-ischemia–associated brain damage has been intensively studied, there is little information about how functional changes depend on the duration of hypoxic exposure. In most experimental models the ischemic-hypoxic period was longer than 5 minutes. Early observations of Gill et al34 have shown that a brief period (5 minutes) of global ischemia already results in consistent neuronal injury.

    In our experiments indomethacin pretreatment had minimal effects on arteriolar dilation to hypoxia. This finding is partly in conflict with recent observations of Coyle et al,35 who showed that indomethacin inhibited hypoxic cerebral vasodilation. In their study the lowest arterial Po2 level was 27 mm Hg, whereas in our study it decreased to 22±1 mm Hg. Hemoglobin O2 binding capacity increases sharply between 20 and 35 mm Hg. A relatively small shift in Po2 levels could mask considerable alterations in the tissue oxygen supply. It has been shown that under hypoxic conditions with an arterial oxygen tension of 35±5 mm Hg, there is an adequate oxygen supply in newborn animals.36

    In conclusion, we found that arterial hypoxia but not extracellular acidosis affects the NMDA-dependent cerebral vasodilation. It is widely accepted that release of excitatory amino acids during hypoxic/anoxic stress is partly responsible for neurological sequelae and that decreased cerebrovascular reactivity to dilatory excitatory amino acids may limit damage. The present observations emphasize the potential beneficial effects of indomethacin or oxygen radical scavenger on the cerebral microcirculation during hypoxia and reperfusion.

    Selected Abbreviations and Acronyms

    aCSF=artificial cerebrospinal fluid
    NOS=nitric oxide synthase
    SNP=sodium nitroprusside
    SOD=superoxide dismutase

          Figure 1.

    Figure 1. Percent change from baseline in diameter of pial arterioles to 10−4 mol/L NMDA under control conditions (n=18) and 30 minutes after 5 or 15 minutes of hypoxic exposure (n=5 and n=6, respectively) and 30 minutes of hypercapnic exposure (n=7). Values are mean±SEM. *P<.05 compared with corresponding control values. ⋆P<.05 for comparison between the 5- and the 15-minute hypoxic groups.

          Figure 2.

    Figure 2. Percent change in diameter of pial arterioles in response to 10−5, 5×10−5, and 10−4 mol/L NMDA before and 30 minutes after 15 minutes of hypoxic hypoxia in the absence (n=6) and in the presence (n=6) of indomethacin treatment (10 mg/kg IV, 20 minutes before onset of hypoxic exposure). Values are mean±SEM. *P<.05 compared with untreated animals.

          Figure 3.

    Figure 3. Percent change from control arteriolar diameter to 10−4 mol/L NMDA before, during, and after 30-minute hypercapnic exposure. Indomethacin was given 20 minutes before onset of hypercapnic exposure (10 mg/kg IV; n=6).

          Figure 4.

    Figure 4. Percent change from baseline arteriolar diameter to topical application of NMDA before and 30 minutes after 15 minutes of hypoxia (n=6). Thirty minutes before the onset of hypoxia, SOD (100 U/mL) was applied topically. At repeated application of NMDA, SOD was also coadministered. Responses after hypoxia were not different than before hypoxia, but they were significantly greater than in untreated animals (Fig 2).

    Table 1. Effects of Hypoxia on Pial Vasodilator Responses to 10−4 mol/L NMDA

    ControlHypoxia30 Minutes After Hypoxia60 Minutes After Hypoxia
     Diameter, μm103±2132±3*104±3121±11*100±5112±7*104±3123±4*
     ΔDiameter, μm28±417±712±5*19±5*
     Pco2, mm Hg34±135±232±134±1
     Po2, mm Hg91±522±1*97±594±5
     Diameter, μm106±4136±3*108±6139±8*104±7124±7*Not tested
     ΔDiameter, μm31±331±820±2*
     Pco2, mm Hg32±132±134±2
     Po2, mm Hg98±422±1*99±5
     Diameter, μm91±4117±680±2*110±9*85±4108±6*84±4111±9*
     ΔDiameter, μm26±630±823±627±5
     Pco2, mm Hg34±136±.132±134±2
     Po2, mm Hg89±722±1*86±589±8
     Diameter, μm102±4130±4*104±5129±7*102±5126±7*Not tested
     ΔDiameter, μm28±425±724±3*
     Pco2, mm Hg33±131±134±2
     Po2, mm Hg91±323±1*97±6

    Values are mean±SEM. Duration of the hypoxic period was 15 minutes in group 1 (n=6) and 5 minutes in group 2 (n=5). Animals in group 3 were treated by indomethacin (10 mg/kg IV) 20 minutes before 15-minute hypoxic exposure. In group 4, SOD (100 U/mL) was applied topically before, during, and after the 15-minute hypoxic exposure. Blood gas and pH values were measured in control conditions and during hypoxic exposures.

    *P<.05 compared with corresponding control.

    Table 2. Effects of Hypercapnia on Pial Vasodilator Responses to 10−4 mol/L NMDA

    ControlDuring Hypercapnia30 Minutes After Hypercapnia
     Vessel diameter, μm94±3126±5*125±6*Not tested99±5124±6*
     ΔDiameter, μm32±725±7
     Pco2, mm Hg34±173±3*35±2
     Po2, mm Hg81±691±688±8
     Vessel diameter, μm104±4141±5*115±9*151±9*109±5140±6*
     ΔDiameter, μm37±536±531±4
     Pco2, mm Hg33±277±4*33±1
     Po2, mm Hg90±780±896±5

    Values are mean±SEM. Duration of the hypercapnic period in both group 5 (n=7) and group 6 (n=6) was 30 minutes. Animals in group 5 were treated by indomethacin (10 mg/kg IV) 20 minutes before hypercapnic exposure. Blood gas and pH values were measured in control conditions and during hypercapnic periods.

    *P<.05 compared with corresponding control.

    This study was supported by grants HL-30260, HL-46558, and HL-50587 from the National Institutes of Health. We thank Merck, Sharpe and Dohme for providing the indomethacin.


    Correspondence to Ferenc Bari, PhD, Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1083.


    • 1 Low JA. The relationship of asphyxia in the mature fetus to long-term neurologic function. Clin Obstet Gynecol.1993; 36:82-90.CrossrefMedlineGoogle Scholar
    • 2 Busija DW, Meng W. Altered cerebrovascular responsiveness to N-methyl-D-aspartate after asphyxia in piglets. Am J Physiol.1993; 265:H389-H394.CrossrefMedlineGoogle Scholar
    • 3 Busija DW, Meng W, Bari F, McGough SP, Errico RA, Tobin JR, Louis TM. Effects of ischemia on cerebrovascular responses to N-methyl-D-aspartate in piglets. Am J Physiol.1996; 270:H1225-H1230.CrossrefMedlineGoogle Scholar
    • 4 Scheetz AJ, Constantine-Paton M. Modulation of NMDA receptor function: implications for vertebrate neural development. FASEB J..1994; 8:745-752.CrossrefMedlineGoogle Scholar
    • 5 Williams K, Romano C, Dichter MA, Molinoff PB. Modulation of the NMDA receptor by polyamines. Life Sci.1991; 48:469-498.CrossrefMedlineGoogle Scholar
    • 6 Gozlan H, Ben-Ari Y. NMDA receptor redox sites: are they targets for selective neuronal protection? Trends Pharmacol Sci..1995; 16:368-374.CrossrefMedlineGoogle Scholar
    • 7 Traynelis SF, Hartley M, Heinemann SF. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science.1995; 268:873-876.CrossrefMedlineGoogle Scholar
    • 8 Mishra OP, Delivoria-Papadopoulos M. NMDA receptor modification in the fetal guinea pig brain during hypoxia. Neurochem Res.1992; 17:1211-1216.CrossrefMedlineGoogle Scholar
    • 9 Armstead, WR, Mirro D, Zuckerman S, Busija DW, Leffler CW. Postischemic generation of superoxide anion by newborn brain. Am J Phys. 1988;H401-H403.Google Scholar
    • 10 Pourcyrous M, Leffler CW, Bada HS, Korones SB, Busija DW. Brain superoxide anion generation in asphyxiated piglets and the effect of indomethacin at therapeutic doses. Pediatr Res.1993; 34:366-369.CrossrefMedlineGoogle Scholar
    • 11 Leffler CW, Busija DW, Beasley DG. Effect of therapeutic dose of indomethacin on the cerebral circulation of newborn pigs. Pediatr Res.1987; 21:188-192.CrossrefMedlineGoogle Scholar
    • 12 Faraci FM, Breese KR. Nitric oxide mediates vasodilatation in response to activation of N-methyl-d-aspartate receptors in the brain. Circ Res.1993; 72:476-480.CrossrefMedlineGoogle Scholar
    • 13 Meng W, Tobin JR, Busija DW. Glutamate-induced cerebral vasodilation is mediated by nitric oxide through N-methyl-d-aspartate receptors. Stroke.1995; 26:857-862.CrossrefMedlineGoogle Scholar
    • 14 Faraci FM, Brian JE. 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to N-methyl-d-aspartate. Stroke.1995; 26:2172-2176.CrossrefMedlineGoogle Scholar
    • 15 Louis TM, Meng W, Bari F, Errico RA, Busija DW. Ischemia reduces CGRP-induced cerebral vascular dilation in piglets. Stroke.1966; 27:134-139.Google Scholar
    • 16 Leffler CW, Beasley DG, Busija DW. Cerebral ischemia alters cerebral microvascular reactivity in newborn pigs. Am J Physiol.1989; 257:H266-H271.MedlineGoogle Scholar
    • 17 Scatton B. The NMDA receptor complex. Fundam Clin Pharmacol..1993; 7:389-400.CrossrefMedlineGoogle Scholar
    • 18 Traynelis SF, Cull-Candy SG. Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature.1990; 345:347-350.CrossrefMedlineGoogle Scholar
    • 19 Hoffman DJ, McGowan JE, Marro PJ, Mishra OP, Delivoria-Papadopoulos M. Hypoxia-induced modification of the N-methyl-D-aspartate receptor in the brain of the newborn piglet. Neurosci Lett.1994; 167:156-160.CrossrefMedlineGoogle Scholar
    • 20 McGowan JE, McGowan JC, Mishra OP, Delivoria-Papadopoulos M. Effect of cyclooxygenase inhibition on brain cell membrane lipid peroxidation during hypoxia in newborn piglets. Biol Neonate..1994; 66:367-375.CrossrefMedlineGoogle Scholar
    • 21 Hammond C, Crépel V, Gozlan H, Ben-Ari Y. Anoxic LTP sheds light on the multiple facets of NMDA receptors. Trends Neurosci..1994; 17:497-503.CrossrefMedlineGoogle Scholar
    • 22 Astrup J, Heuser D, Lassen NA, Nilsson B, Norberg K, Siesjö BK. Evidence against H+ and K+ as main factors for the control of cerebral blood flow: a microelectrode study. In: Elliott K, O'Connor M, eds. Cerebral Vascular Smooth Muscle and its Control. New York, NY: Excerpta Medica; 1979:313-337.Google Scholar
    • 23 Andrews RJ, Bringas JR, Alonzo G. Cerebrospinal fluid pH and PCO2 rapidly follow arterial blood pH and PCO2 with changes in ventilation. Neurosurgery.1994; 34:466-470.CrossrefMedlineGoogle Scholar
    • 24 LaManna JC, Griffith JK, Cordisco BR, Bell HE, Lin CW, Pundik S, Lust WD. Rapid recovery of rat brain intracellular pH after cardiac arrest and resuscitation. Brain Res.1995; 687:175-181.CrossrefMedlineGoogle Scholar
    • 25 Wagerle LC, Mishra OP. Mechanism of CO2 response in cerebral arteries of the newborn pig: role of phospholipase, cyclooxygenase, and lipoxygenase pathways. Circ Res.1988; 62:1019-1026.CrossrefMedlineGoogle Scholar
    • 26 Busija DW, Leffler CW. Dilator effects of amino acid neurotransmitters on piglet pial arterioles. Am J Physiol.1989; 257:H1200-H1203.MedlineGoogle Scholar
    • 27 Dalkara T, Ayata C, Demirci M, Erdemli G, Onur R. Effects of cerebral ischemia on N-methyl-d-aspartate and dihydropyridine-sensitive calcium currents: an electrophysiological study in the rat hippocampus in situ. Stroke.1996; 27:127-133.CrossrefMedlineGoogle Scholar
    • 28 Kristian T, Katsura K, Gido G, Siesjö BK. The influence of pH on cellular calcium influx during ischemia. Brain Res.1994; 641:295-302.CrossrefMedlineGoogle Scholar
    • 29 Obrenovitch TP, Richards DA. Extracellular neurotransmitter changes in cerebral ischaemia. Cerebrovasc Brain Metab Rev.1995; 7:1-54.MedlineGoogle Scholar
    • 30 Silverstein FS, Torke L, Banks J, Johnston MV. Hypoxia-ischemia produces focal disruption of glutamate receptors in developing brain. Dev Brain Res.1987; 34:33-39.CrossrefGoogle Scholar
    • 31 Kontos HA. Oxygen radicals in cerebral vascular injury. Circ Res.1985; 57:508-516.CrossrefMedlineGoogle Scholar
    • 32 Leffler CW, Mirro R, Armstead WM, Busija DW, Thelin O. Prostanoid synthesis and vascular responses to exogenous arachidonic acid following cerebral ischemia in piglets. Prostaglandins.1990; 40:241-248.CrossrefMedlineGoogle Scholar
    • 33 Groenendaal F, Mishra OP, Hoffman DJ, Delivoria-Papadopoulos M. Cerebral nitric oxide synthase acting following hypoxia in newborn piglets. Pediatr Res. 1994;36(suppl):16A. Abstract.Google Scholar
    • 34 Gill R, Foster AC, Woodruff GN. Systemic administration of MK-801 protects against ischemia induced hippocampal neurodegeneration in the gerbil. J Neurosci.1987; 7:3343-3349.CrossrefMedlineGoogle Scholar
    • 35 Coyle MG, Oh W, Stonestreet BS. Effects of indomethacin on brain blood flow and cerebral metabolism in hypoxic newborn piglets. Am J Physiol.1993; 264:H141-H149.MedlineGoogle Scholar
    • 36 Koehler RC, Jones MD, Traystman RJ. Cerebral circulatory response to carbon monoxide and hypoxic hypoxia in the lamb. Am J Physiol.1982; 243:H27-H32.CrossrefMedlineGoogle Scholar
    strokeahaStrokeStrokeStroke0039-24991524-4628Lippincott Williams & Wilkins
    Editorial CommentFaraci Frank M., PhD, Guest Editor091996

    Glutamate is the major excitatory neurotransmitter in the central nervous system of vertebrates. Glutamate and selective glutamate receptor agonists produce dilatation of cerebral blood vessels.1R2R3R4R5R6R7R8R The response to glutamate and receptor agonists is dependent on neuronal activation1R6R and production of nitric oxide,1R2R3R4R5R6R a potent vasodilator. Thus, nitric oxide produced by neurons in response to activation of glutamate receptors appears to couple neuronal activity with local cerebral blood flow.1R

    The cerebral vascular response to glutamate may be impaired under some pathophysiological conditions including ischemia and asphyxia.7R8R In the present study Bari et al examined effects of hypoxia and hypercapnia on responses of cerebral arterioles to the glutamate receptor agonist NMDA. After relatively brief periods of hypoxia (5 to 15 minutes), vasodilator responses to NMDA were impaired. Impaired vasodilatation in response to NMDA could be prevented with indomethacin or SOD, which suggests that superoxide anion, produced via the cyclooxygenase pathway, was the mediator of vascular dysfunction. In contrast to impairment after hypoxia, responses of cerebral arterioles to NMDA were not inhibited by hypercapnia. These findings suggest that hypoxia, but not hypercapnia with accompanying moderate respiratory acidosis, impairs cerebral vasodilatation in response to NMDA.

    Thus, hypoxia can profoundly impair responses of cerebral arterioles to NMDA. The implication of this finding is that hypoxia might also impair a major mechanism to link increases in neuronal activity with blood flow. The findings of the present study do not exclude the possibility that more severe acidosis, such as that which may occur during ischemia, may also alter vascular responses to NMDA.

    Selected Abbreviations and Acronyms

    aCSF=artificial cerebrospinal fluid
    NOS=nitric oxide synthase
    SNP=sodium nitroprusside
    SOD=superoxide dismutase


    eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

    Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.